Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers
- PMID: 24735247
- DOI: 10.3109/10717544.2014.903012
Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers
Abstract
This study aimed to improve the dissolution rate and oral bioavailability of valsartan (VAL), a poorly soluble drug using solid dispersions (SDs). The SDs were prepared by a freeze-drying technique with polyethylene glycol 6000 (PEG6000) and hydroxypropylmethylcellulose (HPMC 100KV) as hydrophilic polymers, sodium hydroxide (NaOH) as an alkalizer, and poloxamer 188 as a surfactant without using any organic solvents. In vitro dissolution rate and physicochemical properties of the SDs were characterized using the USP paddle method, differential scanning calorimetry (DSC), X-ray diffractometry (XRD) and Fourier transform-infrared (FT-IR) spectroscopy, respectively. In addition, the oral bioavailability of SDs in rats was evaluated by using VAL (pure drug) as a reference. The dissolution rates of the SDs were significantly improved at pH 1.2 and pH 6.8 compared to those of the pure drug. The results from DSC, XRD showed that VAL was molecularly dispersed in the SDs as an amorphous form. The FT-IR results suggested that intermolecular hydrogen bonding had formed between VAL and its carriers. The SDs exhibited significantly higher values of AUC 0-24 h and Cmax in comparison with the pure drug. In conclusion, hydrophilic polymer-based SDs prepared by a freeze-drying technique can be a promising method to enhance dissolution rate and oral bioavailability of VAL.
Keywords: Dissolution rate; freeze-drying; oral bioavailability; solid dispersion; valsartan.
Similar articles
-
In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.Pak J Pharm Sci. 2014 Nov;27(6):1799-804. Pak J Pharm Sci. 2014. PMID: 25362604
-
Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.Drug Des Devel Ther. 2015 May 22;9:2745-56. doi: 10.2147/DDDT.S84070. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26045660 Free PMC article.
-
In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.Iran J Pharm Res. 2016 Spring;15(2):385-94. Iran J Pharm Res. 2016. PMID: 27642309 Free PMC article.
-
Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.Ther Deliv. 2019 Jun 1;10(6):363-382. doi: 10.4155/tde-2019-0007. Epub 2019 May 16. Ther Deliv. 2019. PMID: 31094298 Review.
-
Recent Advances in the Surfactant and Controlled Release Polymer-based Solid Dispersion.Curr Pharm Des. 2022;28(20):1643-1659. doi: 10.2174/1381612828666220223095417. Curr Pharm Des. 2022. PMID: 35209818 Review.
Cited by
-
Control of Drug Dissolution Rate from Film Dosage Forms Containing Valsartan.Int Sch Res Notices. 2016 May 23;2016:5135173. doi: 10.1155/2016/5135173. eCollection 2016. Int Sch Res Notices. 2016. PMID: 27382640 Free PMC article.
-
Lyophilized Amorphous Dispersion of Telmisartan in a Combined Carrier-Alkalizer System: Formulation Development and In Vivo Study.ACS Omega. 2020 Dec 10;5(50):32466-32480. doi: 10.1021/acsomega.0c04588. eCollection 2020 Dec 22. ACS Omega. 2020. PMID: 33376884 Free PMC article.
-
Role of Hydrogen Bonds in Formation of Co-amorphous Valsartan/Nicotinamide Compositions of High Solubility and Durability with Anti-hypertension and Anti-COVID-19 Potential.Mol Pharm. 2021 May 3;18(5):1970-1984. doi: 10.1021/acs.molpharmaceut.0c01096. Epub 2021 Apr 1. Mol Pharm. 2021. PMID: 33792313 Free PMC article.
-
Enhancement of Valsartan Oral Bioavailability by Preparing a Microwave-Irradiated Inclusion Complex with Sulfobutyl Ether β-Cyclodextrin Using a Central Composite Face Design for Optimising Process Parameters.AAPS PharmSciTech. 2023 May 9;24(5):115. doi: 10.1208/s12249-023-02571-2. AAPS PharmSciTech. 2023. PMID: 37160765
-
Effect of Shape on Mesoporous Silica Nanoparticles for Oral Delivery of Indomethacin.Pharmaceutics. 2018 Dec 23;11(1):4. doi: 10.3390/pharmaceutics11010004. Pharmaceutics. 2018. PMID: 30583601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources